PremiumThe FlyLabcorp price target raised to $250 from $240 at Barclays Labcorp’s Resilience and Growth Potential: A Reliable Investment Choice Despite Revenue Miss Labcorp Holdings: Strong Q1 2025 Performance and Positive Outlook Justify Buy Rating PremiumThe FlyLabcorp narrows FY25 adjusted EPS view to $15.70-$16.40 from $15.60-$16.40 Notable companies reporting before tomorrow’s open LH Earnings Report this Week: Is It a Buy, Ahead of Earnings? PremiumThe FlyLabcorp launches pTau-217/Beta Amyloid 42 Ratio test for Alzheimer’s Labcorp initiated with a Buy at Redburn Atlantic Labcorp to offer HPV and STI self-collection solutions